Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs7694379
rs7694379 		0.010 GeneticVariation BEFREE SNPs rs342275, rs342293, rs11789898, rs17824620, and rs7694379 can be used as predictors of thrombocytopenia induced by lobaplatin-based chemotherapy in patients with advanced lung cancer in China. 31279707

2019
dbSNP: rs1057519847
rs1057519847
EGFR
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs1057519848
rs1057519848
EGFR
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs1194653703
rs1194653703
PTK2
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs121434568
rs121434568
EGFR
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs1302295057
rs1302295057
EGFR
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs1395763398
rs1395763398
MET
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009
dbSNP: rs2227983
rs2227983
EGFR
0.010 GeneticVariation BEFREE EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer. 18726117

2009
dbSNP: rs762515280
rs762515280
PTK2
0.010 GeneticVariation BEFREE We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib. 19015641

2009